249 related articles for article (PubMed ID: 20005342)
21. Beneficial effects of cyclosporine and rapamycin in small bowel ischemic injury.
Puglisi RN; Strande L; Santos M; Schulte G; Hewitt CW; Whalen TV
J Surg Res; 1996 Oct; 65(2):115-8. PubMed ID: 8903456
[TBL] [Abstract][Full Text] [Related]
22. Effects of immunosuppressive drugs on rat renal ischemia reperfusion injury.
Parra C; Salas P; Dominguez J
Transplant Proc; 2010; 42(1):245-7. PubMed ID: 20172320
[TBL] [Abstract][Full Text] [Related]
23. The effects of rapamycin in the progression of renal fibrosis.
Damião MJ; Bertocchi AP; Monteiro RM; Gonçalves GM; Cenedeze MA; Feitoza CQ; Marques GD; Giannocco G; Mazzali M; Teixeira VP; Dos Reis MA; Pacheco-Silva A; Câmara NO
Transplant Proc; 2007 Mar; 39(2):457-9. PubMed ID: 17362758
[TBL] [Abstract][Full Text] [Related]
24. Beta-chemokine function in experimental lung ischemia-reperfusion injury.
Krishnadasan B; Farivar AS; Naidu BV; Woolley SM; Byrne K; Fraga CH; Mulligan MS
Ann Thorac Surg; 2004 Mar; 77(3):1056-62. PubMed ID: 14992926
[TBL] [Abstract][Full Text] [Related]
25. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction.
Day YJ; Marshall MA; Huang L; McDuffie MJ; Okusa MD; Linden J
Am J Physiol Gastrointest Liver Physiol; 2004 Feb; 286(2):G285-93. PubMed ID: 14715520
[TBL] [Abstract][Full Text] [Related]
26. [Immunosuppression in kidney donors with rapamycin and tacrolimus. Proinflammatory cytokine expression].
Cicora F; Roberti J; Lausada N; González P; Guerrieri D; Stringa P; Raimondi C
Medicina (B Aires); 2012; 72(1):3-9. PubMed ID: 22257448
[TBL] [Abstract][Full Text] [Related]
27. Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice.
Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
Nephrol Dial Transplant; 2008 Sep; 23(9):2768-76. PubMed ID: 18445640
[TBL] [Abstract][Full Text] [Related]
28. The effect of renal ischemia-reperfusion injury on expression of RAE-1 and H60 in mice kidney.
Feng L; Cheng F; Ye Z; Li S; He Y; Yao X; Tang Q; Li Y
Transplant Proc; 2006 Sep; 38(7):2195-8. PubMed ID: 16980040
[TBL] [Abstract][Full Text] [Related]
29. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.
Khan S; Salloum F; Das A; Xi L; Vetrovec GW; Kukreja RC
J Mol Cell Cardiol; 2006 Aug; 41(2):256-64. PubMed ID: 16769083
[TBL] [Abstract][Full Text] [Related]
30. The effect of mTOR-inhibition on NF-κB activity in kidney ischemia-reperfusion injury in mice.
Kezic A; Becker JU; Thaiss F
Transplant Proc; 2013 Jun; 45(5):1708-14. PubMed ID: 23769029
[TBL] [Abstract][Full Text] [Related]
31. Detrimental functions of IL-17A in renal ischemia-reperfusion injury in mice.
Xue L; Xie K; Han X; Yang Z; Qiu J; Zhao Z; Bao T
J Surg Res; 2011 Nov; 171(1):266-74. PubMed ID: 20400117
[TBL] [Abstract][Full Text] [Related]
32. Reduction of ischemia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine.
Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor JL
Transplantation; 2007 Jul; 84(2):187-95. PubMed ID: 17667810
[TBL] [Abstract][Full Text] [Related]
33. Adrenomedullin and adrenomedullin-binding protein-1 downregulate inflammatory cytokines and attenuate tissue injury after gut ischemia-reperfusion.
Carrizo GJ; Wu R; Cui X; Dwivedi AJ; Simms HH; Wang P
Surgery; 2007 Feb; 141(2):245-53. PubMed ID: 17263982
[TBL] [Abstract][Full Text] [Related]
34. Small interfering RNA targeting RelB protects against renal ischemia-reperfusion injury.
Feng B; Chen G; Zheng X; Sun H; Zhang X; Zhang ZX; Xiang Y; Ichim TE; Garcia B; Luke P; Jevnikar AM; Min WP
Transplantation; 2009 May; 87(9):1283-9. PubMed ID: 19424026
[TBL] [Abstract][Full Text] [Related]
35. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
36. Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice.
Yoshidome H; Lentsch AB; Cheadle WG; Miller FN; Edwards MJ
J Surg Res; 1999 Jan; 81(1):33-7. PubMed ID: 9889054
[TBL] [Abstract][Full Text] [Related]
37. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion.
Liang H; Xu F; Zhang T; Huang J; Guan Q; Wang H; Huang Q
Biomed Pharmacother; 2018 Oct; 106():879-889. PubMed ID: 30119258
[TBL] [Abstract][Full Text] [Related]
39. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway.
Wang H; Li ZY; Wu HS; Wang Y; Jiang CF; Zheng QC; Zhang JX
Chin Med J (Engl); 2007 Mar; 120(6):509-14. PubMed ID: 17439747
[TBL] [Abstract][Full Text] [Related]
40. Stathmin-deficient mice develop fibrosis and show delayed recovery from ischemic-reperfusion injury.
Zahedi K; Revelo MP; Barone S; Wang Z; Tehrani K; Citron DP; Bissler JJ; Rabb H; Soleimani M
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1559-67. PubMed ID: 16434570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]